AI assistant
CONMED Corp — Director's Dealing 2014
Jun 3, 2014
31971_dirs_2014-06-03_d4ab3ee2-ffed-4538-bc06-c3ae31d0b08f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-06-01
Reporting Person: Darling Joseph G (EVP, Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 7125 | Direct |
| 2014-06-01 | Common Stock | F | 212 | $44.90 | Disposed | 6913 | Direct |
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 7713 | Direct |
| 2014-06-01 | Common Stock | F | 212 | $44.90 | Disposed | 7501 | Direct |
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 8301 | Direct |
| 2014-06-01 | Common Stock | F | 212 | $44.90 | Disposed | 8089 | Direct |
| 2014-06-01 | Common Stock | M | 2000 | — | Acquired | 10089 | Direct |
| 2014-06-01 | Common Stock | F | 529 | $44.90 | Disposed | 9560 | Direct |
| 2014-06-01 | Common Stock | M | 2100 | — | Acquired | 11660 | Direct |
| 2014-06-01 | Common Stock | F | 556 | $44.90 | Disposed | 11104 | Direct |
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 11904 | Direct |
| 2014-06-01 | Common Stock | F | 212 | $44.90 | Disposed | 11692 | Direct |
| 2014-06-01 | Common Stock | M | 800 | — | Acquired | 12492 | Direct |
| 2014-06-01 | Common Stock | F | 212 | $44.90 | Disposed | 12280 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2020-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | PSUs (Performance Stock Units) | $0 | M | 2000 | Disposed | 2021-06-01 | Common Stock (2000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 2100 | Disposed | 2021-07-29 | Common Stock (2100) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2022-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2023-06-01 | Common Stock (800) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | A | 2600 | Acquired | 2024-06-01 | Common Stock (2600) | Direct |
| 2014-06-01 | Sars (Stock Appreciation Rights) | $44.90 | A | 6500 | Acquired | 2024-06-01 | Common Stock (6500) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F2: Each performance share unit (PSU) represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long- Term Incentive Plan, with the PSUs generally vesting over a five year period. The performance share units vest upon the achievement of performance goals.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year starting June 1, 2012 and 15% vesting in the sixth and seventh year.
F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.